MAC volumes and pricing update spark interest in Deterra Royalties
Deterra Royalties (ASX:DRR) has drawn fresh attention after reporting June quarter MAC sales of 37.5 Mdmt at implied average revenue of A$133.9 per tonne, alongside BHP reported MAC production of 39.7 Mwmt.
See our latest analysis for Deterra Royalties.
Against this backdrop, Deterra Royalties’ share price has A$4.36 as the latest close, with a 1 day share price return of 1.16% and a 1 year total shareholder return of 5.83%. This points to steady rather than rapid momentum as the market digests the new MAC volume and pricing data.
If this update has you looking beyond a single royalty stock, it could be a useful moment to scan the broader miner and metals space through our rare earths focused stock screener, which highlights 28 best rare earth metal stocks.
Deterra Royalties has inched higher on the MAC update, which puts you at a fork in the road. Is this the moment to commit at A$4.36, or does the valuation still argue for patience and a better entry?
Most Popular Narrative: 6.2% Undervalued
The most followed narrative puts Deterra Royalties’ fair value at A$4.65, compared with the latest A$4.36 close. That small gap rests on some punchy long term assumptions.
The analysts have a consensus price target of A$4.65 for Deterra Royalties based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of A$5.5, and the most bearish reporting a price target of just A$3.95.
Want to see what justifies pricing Deterra Royalties only slightly above today’s A$4.36 level? The narrative leans on specific revenue paths, margin shifts, and a materially higher future earnings multiple. The mix of declining top line forecasts and rich valuation assumptions is where the real story sits.
Result: Fair Value of A$4.65 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there are also risks that could flip this Deterra Royalties story, including weaker iron ore demand and any stumble in new lithium or gold royalty projects.
Find out about the key risks to this Deterra Royalties narrative.
Another View on Deterra Royalties Valuation
The first narrative frames Deterra Royalties as modestly undervalued at A$4.65 fair value, but the P/E picture is less forgiving. The stock trades on a 12.9x P/E, which is higher than the Australian Metals and Mining industry at 12.2x and above a fair ratio of 10x. That gap suggests investors are already paying a premium, so how comfortable are you with this if earnings and revenue are expected to decline?
For a closer look at what this price gap might mean in practice, including how it compares with other companies using the same yardstick, See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Given the mixed signals around Deterra Royalties, it makes sense to review the full risk and reward picture and reach your own verdict. To weigh up what concerns other investors and what they see as potential upside, start with these 2 key rewards and 3 important warning signs
Looking for more investment ideas beyond Deterra Royalties?
If Deterra Royalties has sharpened your focus, broaden your watchlist using the Simply Wall St screener to spot other opportunities that could fit your goals.
- Target dependable cash generators by checking companies with resilient earnings and strong finances through the solid balance sheet and fundamentals stocks screener (19 results).
- Hunt for potential value candidates by focusing on quality businesses trading below what their fundamentals might justify using the 9 high quality undervalued stocks.
- Seek out income focused opportunities by reviewing stocks that combine higher yields with more robust payout profiles via the 4 dividend fortresses.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com